Equities

Neuberger Berman High Yield Strategies

Neuberger Berman High Yield Strategies

Actions
Financials
  • Price (USD)11.85
  • Today's Change0.02 / 0.17%
  • Shares traded28.54k
  • 1 Year change7.53%
  • Beta0.6790
Data delayed at least 15 minutes, as of Apr 24 2019 19:02 BST.
More ▼

Events & Activity

  • NHS:ASQ price reached a new 52-week high of 11.85 at 10:30 BST
  • NHS:ASQ price moved over -1.01% to 11.71
  • On date 29 Mar 2019, NHS:ASQ announced a new dividend of amount 0.0658 payable on date 29 Mar 2019

Key statistics

Neuberger Berman High Yield Strategies (NHS:ASQ) set a new 52-week high during today's trading session when it reached 11.85. Over this period, the share price is up 7.73%.
52-week range
Today
9.15Dec 26 201811.85Apr 24 2019
Markit short selling activity
Low
Med
High
Open11.85
High11.85
Low11.84
Bid11.84
Offer11.85
Previous close11.83
Average volume81.50k
Shares outstanding19.54m
Free float19.53m
P/E (TTM)3.22
Market cap231.17m USD
EPS (TTM)3.68
USD
Annual div (ADY)1.09
USD
Annual div yield (ADY)9.18%
Div ex-dateApr 12 2019
Div pay-dateApr 30 2019
Next div ex-dateMay 14 2019
Next div pay-dateMay 31 2019
Data delayed at least 15 minutes, as of Apr 24 2019 19:02 BST.
More ▼
All data shown on this page, unless noted otherwise is Data Source and Copyright: Morningstar, Inc. 2019
All Rights reserved
© 2019 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.